GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, ADRB1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, F2, F3, FABP3, FABP4, FLT3, GPER1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HCAR2, HSD11B1, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, KIT, MAOA, MET, MIF, POLA1, POLB, PPARA, PRKCD, SLC1A1, SMAD3, SRC, TEK, TERT, XDH |
13.034 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
12.3015 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.5686 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CA3, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ERBB2, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, GRIK5, GRM5, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MMP2, POLB, PPARA, PRKCD, PTGES, SMAD3, SRC, TEK, TYR |
11.5651 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CA3, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ESR1, ESRRA, FABP3, GPER1, GRIK5, GRM5, HSD17B2, IGF1R, INSR, MMP2, MMP9, POLB, PPARA, PRKCD, PTGES, SRC, TEK, TYR |
11.5651 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CA3, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ERBB2, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, GRIK5, GRM5, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MMP2, MMP9, POLB, PPARA, PRKCD, PTGES, SMAD3, SRC, TEK, TERT, TYR |
10.895 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRB1, AKR1B1, APP, AR, AURKB, AXL, BACE1, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESR2, F2, F3, FLT3, GPER1, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, NUAK1, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
10.4287 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, AR, BCL2, CSNK2A1, CYP1B1, DNMT1, EGFR, ERBB2, ESR1, ESRRA, F2, F3, FABP3, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP2, MMP9, NUAK1, PIM1, PTGES, SMAD3, SRC, TEK, TERT, XDH |
10.4109 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRB1, AKR1B1, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, F2, F3, FLT3, GPER1, GPR35, GRM1, HCAR2, HSPA1A, INSR, KDR, KIT, MET, MIF, MMP9, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
10.3639 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRB1, AKR1B1, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, F2, F3, FLT3, GPER1, GPR35, GRM1, HCAR2, HSPA1A, INSR, KDR, KIT, MET, MIF, MMP9, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
10.3639 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
10.3639 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRB1, AKR1B1, APP, AR, AURKB, AXL, BACE1, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESR2, F2, F3, FLT3, GPER1, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, NUAK1, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
10.3639 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DNMT1, EGFR, ERBB2, ESR1, ESRRA, FABP3, FLT3, GPER1, GRM5, IGF1R, INSR, KIT, MMP2, PPARA, PRKCD, SMAD3, SRC, TEK |
10.3481 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, EGFR, ERBB2, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, HSD17B2, KIT, MET, MIF, PPARA, PTGES, TBXAS1 |
9.96788 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, F2, F3, FLT3, GPER1, GPR35, GRM1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, NUAK1, PRKCD, SRC, TEK, XDH |
9.28926 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, APP, AR, AXL, BCL2, CYP1B1, EGFR, ERBB2, F2, F3, FLT3, GPER1, GPR35, GRM1, HSPA1A, INSR, KDR, KIT, MET, MIF, SRC, TEK, XDH |
8.75638 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ERBB2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, INSR, KDR, KIT, POLB, PPARA, SMAD3, SRC, TEK, TYR |
8.58841 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APP, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, FUT7, HSPA1A, MIF, PIM1, PPARA, PTGES, TBXAS1, TYR, XDH |
8.58841 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, DYRK1A, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, PRKCD, SRC, TEK |
8.56549 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, DYRK1A, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, PRKCD, SRC, TEK |
8.49957 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRB1, AKR1B1, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ERBB2, F2, F3, FLT3, GPER1, GPR35, GRM1, HSPA1A, INSR, KDR, KIT, MET, MIF, MMP9, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
8.49957 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, DYRK1A, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, PIM1, SRC, TEK |
8.31544 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRB1, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, F2, FABP3, FABP4, FLT3, GPER1, GPR35, GRIK5, GRM1, GRM5, INSR, MET, POLA1, POLB, SMAD3, SRC, TERT |
8.10346 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ERBB2, ESR1, FABP4, FLT3, GPER1, GRIK5, GRM5, HSPA1A, IGF1R, INSR, KDR, KIT, MMP2, MMP9, PRKCD, SMAD3, SRC, TERT |
7.97447 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, GPER1, INSR, KIT, PPARA, PRKCD, SRC, TEK |
7.86478 |
[BP] GO:0007215 |
None
|
APP, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.82725 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRB1, APP, AR, BCL2, DUSP3, EGFR, ERBB2, ESRRB, F2, FABP3, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, KIT, MIF, MMP9, NUAK1, PPARA, PRKCD, SMAD3, SRC, TEK, XDH |
7.82061 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MIF, PTGES, TBXAS1 |
7.82061 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GPER1, GRIK5, HCAR2, HSPA1A, IGF1R, KDR, KIT, MET, MIF, MMP9, PIM1, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
7.79511 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRB1, APP, AR, BCL2, DUSP3, EGFR, ERBB2, ESRRB, F2, FABP3, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, KIT, MIF, MMP9, NUAK1, PPARA, PRKCD, SMAD3, SRC, TEK, XDH |
7.77207 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GPER1, GRIK5, HCAR2, HSPA1A, IGF1R, KDR, KIT, MET, MIF, MMP9, PIM1, PPARA, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
7.76955 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, KIT, MMP9, PRKCD, PTGES, SRC, TERT |
7.66877 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MIF, PTGES, TBXAS1 |
7.57314 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, BCL2, CACNA1C, CYP19A1, CYP1B1, EGFR, ERBB2, F3, GPER1, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, SMAD3, SRC, TEK, TERT |
7.29516 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, BACE1, CA2, CA7, EGFR, GPER1, GRIK5, GRM1, GRM3, GRM5, GRM8, KIT |
7.26427 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, BACE1, CA2, CA7, EGFR, GPER1, GRIK5, GRM1, GRM3, GRM5, GRM8, KIT |
7.26427 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, ESR1, HSD11B1, HSD17B1, HSD17B2 |
7.25264 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGES, TBXAS1 |
7.22132 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AR, AURKB, BCL2, CYP1A1, EGFR, ERBB2, ESR1, FLT3, KIT, MET, MIF, PIM1, POLA1, PRKCD, SRC, TEK, TYR |
7.21439 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ERBB2, ESR1, FABP4, FLT3, GPER1, GRIK5, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP2, MMP9, NUAK1, POLA1, POLB, PRKCD, SMAD3, SRC, TERT |
7.21439 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRB1, APP, AR, BCL2, EGFR, ERBB2, ESRRB, F2, FABP3, FLT3, GPER1, GRM1, GRM5, INSR, KDR, KIT, MIF, MMP9, PRKCD, SMAD3, SRC, TEK, XDH |
7.21439 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRB1, APP, AR, BCL2, EGFR, ERBB2, ESRRB, F2, FABP3, FLT3, GPER1, GRM1, GRM5, INSR, KDR, KIT, MIF, MMP9, PRKCD, SMAD3, SRC, TEK, XDH |
7.21439 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA3, APP, AR, AXL, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, F2, F3, GPER1, GPR35, GRIK5, GRM5, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, PPARA, PRKCD, SMAD3, SRC, TEK, TERT |
7.21439 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, EGFR, ERBB2, F3, GPER1, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, SMAD3, SRC, TEK, TERT |
7.21439 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1B1, DNMT1, EGFR, ERBB2, ESR1, FABP4, FLT3, GPER1, GRIK5, GRM5, IGF1R, INSR, KDR, KIT, MMP2, PRKCD, SMAD3, SRC |
7.11052 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRB1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FLT3, GPER1, GPR35, GRIK5, GRM1, GRM5, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP2, MMP9, PIM1, PPARA, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
7.02516 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA3, CA6, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, EGFR, ERBB2, ESR1, ESRRA, F2, F3, FABP3, FABP4, FLT3, GPER1, GRIK5, GRM1, GRM5, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP2, MMP9, NUAK1, POLA1, POLB, PPARA, PRKCD, PTGES, SMAD3, SRC, TEK, TERT, TYR |
6.97131 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRB1, AKR1B1, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ERBB2, ESRRA, F2, F3, FABP4, FLT3, GPER1, GPR35, GRM1, HSPA1A, INSR, KDR, KIT, MET, MIF, MMP2, MMP9, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
6.91967 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, KIT, MET, MIF, MMP9, PIM1, PPARA, PRKCD, SMAD3, SRC, TEK, TERT |
6.9162 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, EGFR, F3, GPER1, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, SMAD3, SRC, TEK, TERT |
6.91237 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, KIT, MET, MIF, MMP9, PIM1, PRKCD, SMAD3, SRC, TEK, TERT |
6.84357 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, ADRB1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DNMT1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOA, MET, MIF, MMP1, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PRKCD, PTGES, SMAD3, SRC, TBXAS1, TEK, TERT, TYR, XDH |
6.81067 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, BCL2, CSNK2A1, EGFR, ERBB2, ESR1, F2, F3, FLT3, GPER1, IGF1R, INSR, KDR, KIT, MIF, MMP2, MMP9, PIM1, TEK, TERT |
6.71835 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, ADRB1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, GPER1, GPR35, GRIK5, GRM1, GRM5, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP2, MMP9, PIM1, PPARA, PRKCD, SLC1A1, SMAD3, SRC, TEK, TERT, XDH |
6.68257 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GPER1, GRIK5, HCAR2, HSPA1A, IGF1R, KDR, MIF, MMP9, PIM1, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
6.68257 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, EGFR, ERBB2, F3, GPER1, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, SMAD3, SRC, TEK, TERT |
6.68257 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA1, ADORA3, ADRB1, APP, AR, AURKB, BCL2, CSNK2A1, CYP1B1, CYP2D6, DUSP3, EGFR, ERBB2, ESR1, ESR2, F2, F3, FABP4, FLT3, GPER1, GPR35, GRM1, GRM3, GRM5, HSPA1A, IGF1R, INSR, KIT, MET, MIF, MMP9, NUAK1, PIM1, PPARA, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
6.64938 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, ADORA1, ADRB1, APP, AR, AURKB, BCL2, EGFR, ERBB2, ESR1, ESR2, F2, F3, FLT3, GPER1, GRM1, GRM5, HSPA1A, INSR, KIT, MET, MIF, MMP9, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
6.64938 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, GPER1, HSD17B2, PTGES, SRC, TYR |
6.63366 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FLT3, GPER1, PTGES, SRC, TEK, TYR |
6.59207 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, SLC1A1 |
6.57805 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRB1, AKR1B1, APP, AR, AXL, BCL2, CA1, CA2, CACNA1C, CSNK2A1, CYP1B1, DNMT1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GPER1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, KIT, MET, MIF, MMP2, MMP9, NUAK1, PIM1, POLB, PPARA, PRKCD, PTGES, SMAD3, SRC, TEK |
6.54639 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, EGFR, ERBB2, F2, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, KIT, MET, MIF, MMP2, MMP9, PRKCD, SMAD3, SRC, TEK |
6.42655 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRB1, APP, AR, AURKB, BCL2, CSNK2A1, DUSP3, EGFR, ERBB2, ESR1, F2, F3, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, HSPA1A, IGF1R, INSR, KIT, MIF, MMP9, NUAK1, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
6.40189 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, EGFR, F3, GPER1, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK, TERT |
6.26758 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DNMT1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOA, MET, MIF, MMP1, MMP2, NUAK1, PIM1, POLA1, POLB, PPARA, PRKCD, PTGES, SMAD3, SRC, TBXAS1, TEK, TERT, TYR, XDH |
6.24178 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MIF, PTGES, TBXAS1 |
6.15165 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, EGFR, ERBB2, FABP3, FABP4, FUT7, KIT, MET, MIF, PPARA, PTGES, TBXAS1 |
6.14999 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, EGFR, F3, GPER1, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK, TERT |
6.09611 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, APP, AR, BCL2, CSNK2A1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, F2, F3, FLT3, GPER1, GRM1, GRM5, HSPA1A, INSR, KDR, KIT, MIF, MMP9, PRKCD, SMAD3, SRC, TEK, XDH |
6.09131 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, ERBB2, F3, GPER1, INSR, KIT, MET, SRC, TEK, XDH |
6.00129 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, AR, BCL2, EGFR, ERBB2, ESRRB, F2, FLT3, GPER1, GRM1, GRM5, INSR, KDR, KIT, MIF, MMP9, PRKCD, SRC, TEK, XDH |
5.9719 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, EGFR, F3, GPER1, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK, TERT |
5.94989 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, APP, AR, BCL2, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, F2, F3, FLT3, GPER1, GRM1, GRM5, HSPA1A, INSR, KDR, KIT, MIF, MMP9, PRKCD, SMAD3, SRC, TEK, XDH |
5.9427 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, APP, AR, DUSP3, EGFR, ERBB2, FLT3, GPER1, GRM1, IGF1R, INSR, KDR, KIT, MIF, PRKCD, SRC, TEK, XDH |
5.9193 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRB1, APP, AR, AXL, BCL2, CA2, CACNA1C, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, ESRRB, F2, F3, GPER1, GPR35, GRM1, HCAR2, HSPA1A, INSR, KDR, KIT, MET, MIF, MMP9, PIM1, PRKCD, SLC1A1, SMAD3, SRC, TEK, TERT, XDH |
5.81429 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRB1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AXL, BCL2, CACNA1C, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRB, F2, F3, FABP4, GPER1, GRM1, GRM5, GRM8, HSD17B2, IGF1R, INSR, KIT, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PRKCD, SMAD3, SRC, TEK, TYR |
5.81184 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, EGFR, F3, GPER1, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK, TERT |
5.78061 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, APP, CYP19A1, DUSP3, DYRK1A, EGFR, ESR1, F2, F3, FABP4, GPER1, HSPA1A, IGF1R, MET, MIF, MMP2, NUAK1, PPARA, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
5.71465 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, BCL2, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, F2, FABP3, FABP4, GPER1, GPR35, GRIK5, GRM1, GRM5, INSR, MET, SMAD3 |
5.61898 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, AR, BCL2, EGFR, ERBB2, F2, FLT3, GPER1, GRM1, GRM5, INSR, KDR, KIT, MIF, MMP9, PRKCD, SRC, TEK, XDH |
5.60742 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRB1, APP, AR, AURKB, BCL2, CSNK2A1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GPER1, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, PPARA, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
5.57914 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MIF, MMP9, PIM1, PRKCD, SMAD3, SRC, TEK, TERT |
5.57914 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PPARA, PTGES, TBXAS1 |
5.57914 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRB1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESR2, F2, F3, FLT3, GPER1, GPR35, GRM1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, NUAK1, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
5.55919 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, AR, EGFR, ERBB2, FLT3, GPER1, GRM1, INSR, KDR, KIT, MIF, SRC, TEK, XDH |
5.55919 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.54896 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.54896 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, AR, BCL2, DUSP3, EGFR, ERBB2, ESRRB, F2, FABP4, FLT3, GPER1, GRM1, GRM5, IGF1R, INSR, KDR, KIT, MIF, MMP9, PPARA, PRKCD, SRC, TEK, XDH |
5.51386 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, AR, DNMT1, EGFR, ERBB2, ESR1, FLT3, GPER1, GRM5, IGF1R, INSR, KIT, MMP2, PRKCD, SMAD3, SRC |
5.51211 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGES, TBXAS1 |
5.4077 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, APP, AR, BCL2, DNMT1, DUSP3, DYRK1A, EGFR, ERBB2, F2, FABP4, FLT3, GPER1, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP9, NUAK1, PRKCD, SRC, TEK, XDH |
5.39435 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRB1, APP, AR, AXL, BCL2, CA2, CYP1B1, EGFR, ESRRB, F2, F3, GPER1, HCAR2, HSPA1A, KDR, KIT, MET, MIF, MMP9, PIM1, SLC1A1, SMAD3, SRC, TEK, TERT |
5.36806 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRB1, APP, AURKB, BCL2, EGFR, ERBB2, ESR1, F2, F3, FLT3, GPER1, GRM1, GRM5, HSPA1A, INSR, KIT, MIF, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
5.35163 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, APP, AR, BCL2, DNMT1, DYRK1A, EGFR, ERBB2, F2, FLT3, GPER1, GRM1, GRM5, INSR, KDR, KIT, MIF, MMP9, PRKCD, SRC, TEK, XDH |
5.28698 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, ADRB1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, F2, F3, FABP4, FLT3, GPER1, GPR35, GRM1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP2, MMP9, NUAK1, PPARA, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
5.27078 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, ADRB1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, EGFR, GRM1, HSPA1A, KIT, MMP2, POLB, PPARA, SMAD3, SRC, TEK, TERT, TYR |
5.25577 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, SLC1A1 |
5.24017 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRB1, APP, AR, AURKB, BCL2, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FLT3, GPER1, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, PPARA, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
5.21243 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.20502 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, ERBB2, F3, INSR, KIT, MET, SRC, TEK |
5.19263 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESRRA, ESRRB, F2, FLT3, HSD11B1, HSD17B2, INSR, KDR, KIT, MMP9, PIM1, POLB, PPARA, SMAD3, SRC, TEK, TYR |
5.1429 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, PRKCD, SRC, TEK |
5.127 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.06911 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESRRA, ESRRB, F2, FABP4, FLT3, FUT7, HSD11B1, HSD17B2, INSR, KDR, KIT, MET, MIF, MMP2, MMP9, PIM1, POLB, PPARA, PRKCD, SMAD3, SRC, TEK, TERT, TYR |
5.06911 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CSNK2A1, DYRK1A, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PRKCD, SRC, TEK |
5.04297 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, AR, BCL2, CYP19A1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESR2, F2, GPER1, HSPA1A, IGF1R, MET, MIF, MMP9, PPARA, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
5.03314 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, APP, AXL, BCL2, CA2, CA7, CACNA1C, CYP19A1, EGFR, ERBB2, F2, GPER1, GPR35, GRIK5, GRM5, HCAR2, HSPA1A, INSR, MIF, MMP9, PPARA, PRKCD, SMAD3, SRC, TERT |
5.0226 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, ERBB2, FLT3, GRM1, IGF1R, INSR, KIT, MIF, PRKCD, SRC |
5.02033 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, F2, GPER1, PPARA, PRKCD, SMAD3, TEK |
5.00166 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, APP, AR, BCL2, DUSP3, EGFR, ERBB2, F2, FABP4, FLT3, GPER1, GRM1, GRM5, IGF1R, INSR, KDR, KIT, MIF, MMP9, PRKCD, SRC, TEK, XDH |
4.99296 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CYP1B1, DNMT1, EGFR, ESR1, GPER1, GRIK5, GRM5, IGF1R, INSR, MMP2, MMP9, PRKCD, SRC |
4.97916 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DNMT1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, GPER1, GPR35, GRM3, GRM8, HSPA1A, IGF1R, KDR, KIT, MET, MIF, MMP9, PIM1, PPARA, PRKCD, PTGES, SMAD3, SRC, TEK, TERT, XDH |
4.9227 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, AR, BCL2, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESR2, GPER1, GPR35, HSPA1A, IGF1R, MET, MIF, MMP9, PRKCD, SMAD3, SRC, TERT, XDH |
4.89807 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7, GRM5 |
4.88426 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, APP, AXL, BCL2, CA2, CYP19A1, EGFR, ERBB2, F2, GPER1, HCAR2, INSR, MIF, PRKCD, SMAD3, SRC, TERT |
4.88408 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, AR, BCL2, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESR2, GPER1, GPR35, HSPA1A, IGF1R, MET, MIF, MMP9, PRKCD, SMAD3, SRC, TERT, XDH |
4.88267 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, GPER1, HCAR2, HSD11B1, HSD17B1, HSD17B2 |
4.83328 |
[BP] GO:0044070 |
regulation of anion transport
|
ABCB1, ADORA1, CA2, CA7, GRM5, MIF, PRKCD |
4.80608 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
F2, FABP3, FLT3, KIT, PPARA, PRKCD, SRC, TEK |
4.80446 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRB1, APP, AR, AURKB, BCL2, CSNK2A1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FLT3, GPER1, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, PPARA, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
4.78158 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, F2, FABP3, FLT3, GPER1, HCAR2, KIT, PPARA, PRKCD, SRC, TEK |
4.75297 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PIM1, PPARA, SRC |
4.74275 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CSNK2A1, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GPER1, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, PPARA, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
4.69745 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD11B1, HSD17B1, HSD17B2, MAOA, TBXAS1, TYR, XDH |
4.6696 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, EGFR, ERBB2, F2, PPARA, SMAD3 |
4.66674 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, SRC |
4.63905 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD17B1, HSD17B2 |
4.55002 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DNMT1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, GPER1, GPR35, GRM3, GRM8, HCAR2, HSPA1A, IGF1R, KDR, KIT, MET, MIF, MMP9, PIM1, PPARA, PRKCD, PTGES, SMAD3, SRC, TEK, TERT, XDH |
4.54288 |
[BP] GO:0010038 |
response to metal ion
|
APP, BCL2, CA2, CYP1A1, CYP1A2, EGFR, FABP4, KIT, MMP9, PTGES, TERT |
4.41597 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, EGFR, GRM1, GRM3, GRM5, GRM8 |
4.37403 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, CACNA1C, EGFR, F2, GPER1, HCAR2, KDR, MIF, SRC |
4.37403 |
[BP] GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling
|
EGFR, F2, FLT3, GPER1, KDR, KIT, TEK |
4.34055 |
[BP] GO:0042391 |
None
|
ADORA1, APP, BCL2, CACNA1C, GPER1, GPR35, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
4.33132 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.30986 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, DUSP3, EGFR, ERBB2, F2, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, KIT, MIF, PRKCD, SRC, TEK |
4.30986 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AR, AURKB, AXL, BCL2, DNMT1, ESR1, GPER1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP9, PRKCD, SMAD3, SRC, TEK |
4.29138 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DNMT1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, FUT7, GPER1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOA, MET, MIF, MMP1, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PRKCD, PTGES, SLC1A1, SMAD3, SRC, TBXAS1, TEK, TERT, TYR, XDH |
4.28349 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
F2, FLT3, KIT, SRC, TEK |
4.27848 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.27848 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DNMT1, EGFR, FABP3, FLT3, GPER1, GRM5, IGF1R, INSR, MMP2, PPARA, PRKCD, SRC, TEK, TYR |
4.25267 |
[BP] GO:0050801 |
ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, F2, FABP3, GPER1, GPR35, GRM1, GRM5, SMAD3 |
4.22667 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, PRKCD, SRC, TERT |
4.21909 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, SRC, TEK |
4.1707 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, CACNA1C, F2, GPER1, KDR, SRC |
4.1707 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, BCL2, CA3, CYP1B1, EGFR, HSPA1A, MMP9, PRKCD, SRC |
4.15569 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, CYP2D6, MET, MMP9, PPARA, PRKCD, SMAD3, SRC, TERT |
4.15569 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DYRK1A, EGFR, ERBB2, F2, FLT3, IGF1R, INSR, KDR, KIT, MET, PRKCD, SRC, TEK |
4.14644 |
[BP] GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling
|
F2, FLT3, GPER1, KDR, KIT, TEK |
4.13273 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CA3, CSNK2A1, DUSP3, DYRK1A, EGFR, ERBB2, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, POLB, PRKCD, SRC, TEK, XDH |
4.09038 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, GPER1, GRM5, IGF1R, INSR, PPARA, PRKCD, SRC, TEK |
4.09038 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.07956 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, PRKCD, SRC |
4.07956 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DUSP3, DYRK1A, ESR1, GPER1, HSPA1A, IGF1R, MET, MIF, MMP9, PRKCD, SRC, XDH |
4.0212 |
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, ADORA1, APP, BCL2, CA2, CA7, CACNA1C, F2, GPER1, GPR35, GRM5, MIF, MMP9, PRKCD |
3.99928 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, APP, AR, BCL2, CSNK2A1, DNMT1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, F2, F3, FABP4, FLT3, GPER1, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP9, NUAK1, PRKCD, SMAD3, SRC, TEK, XDH |
3.99583 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, APP, AXL, BCL2, CA2, CA3, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, F2, GPER1, HSPA1A, KIT, MIF, MMP2, MMP9, NUAK1, POLA1, POLB, PPARA, PRKCD, PTGES, SMAD3, SRC, TEK, TERT |
3.97388 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, DUSP3, EGFR, ERBB2, F2, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, KIT, MIF, PRKCD, SRC, TEK |
3.96635 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, PRKCD, SRC, TEK |
3.9327 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, POLB, PPARA, SMAD3, SRC, TEK, TERT |
3.9327 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, SRC |
3.90223 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DNMT1, EGFR, FABP3, FLT3, GPER1, GRM5, IGF1R, INSR, MMP2, PPARA, PRKCD, SRC, TEK, TYR |
3.86738 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, F2, INSR, PRKCD, SMAD3, XDH |
3.86738 |
[BP] GO:0050730 |
None
|
ADORA1, APP, EGFR, FLT3, GRM5, KIT, MIF, PRKCD, SRC |
3.83825 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, F2, GPER1, PPARA, PRKCD, SMAD3, TEK |
3.833 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CSNK2A1, DYRK1A, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PRKCD, SRC, TEK |
3.82985 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, EGFR, MMP9, PRKCD, SRC |
3.7803 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, EGFR, ERBB2, F2, FLT3, GRM1, GRM5, INSR, KIT, MIF, PRKCD, SRC, TEK |
3.77292 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRB1, AKR1B1, AXL, BCL2, CACNA1C, CYP1B1, DNMT1, EGFR, ERBB2, GPER1, GRM5, IGF1R, INSR, KDR, KIT, MET, MIF, NUAK1, POLB, PRKCD, SRC, TEK |
3.76033 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CA3, CSNK2A1, DUSP3, DYRK1A, EGFR, ERBB2, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, POLB, PRKCD, SRC, TEK, XDH |
3.75873 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, F2, GPER1, GPR35, GRM1, GRM5, SMAD3 |
3.7581 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, F2, FABP4, GPER1, PPARA, PRKCD, SMAD3, TEK |
3.69139 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CSNK2A1, CYP2D6, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, F2, FABP4, GPER1, GRM3, GRM8, HCAR2, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, PPARA, PRKCD, SMAD3, SRC, TERT, XDH |
3.67203 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
AR, BCL2, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESR2, GPER1, HSPA1A, IGF1R, MET, MIF, MMP9, PRKCD, SMAD3, SRC, TERT, XDH |
3.67203 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DNMT1, EGFR, GPER1, GRM5, IGF1R, INSR, MMP2, PRKCD, SRC |
3.62228 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PPARA, PTGES, TBXAS1 |
3.6186 |
[BP] GO:1900182 |
positive regulation of protein localization to nucleus
|
APP, EGFR, F2, PRKCD, SMAD3, SRC, TERT |
3.59193 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.58838 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CA3, CYP1A1, CYP1B1, KDR, POLB, PRKCD, SRC |
3.55841 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, SMAD3, SRC, TEK |
3.53172 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, EGFR, GPER1, GRIK5, INSR, MAOA, SLC1A1, SMAD3 |
3.52212 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, SMAD3, SRC, TEK, TERT |
3.47367 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, EGFR, ESR1, F2, F3, FABP4, GPER1, KDR, MET, MIF, PPARA, PRKCD, SMAD3, TEK |
3.47367 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, PRKCD, SRC |
3.46804 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, EGFR, ERBB2, F2, FLT3, GRM1, GRM5, INSR, KIT, MIF, PRKCD, SRC, TEK |
3.4635 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, DUSP3, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, KIT, MIF, PRKCD, SRC |
3.43894 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DUSP3, EGFR, ERBB2, FLT3, GRM1, IGF1R, INSR, KIT, MIF, PRKCD, SRC |
3.42845 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, F2, INSR, PRKCD, SMAD3, XDH |
3.4269 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
APP, BCL2, CACNA1C, EGFR, ESR1, F2, GPER1, GPR35, GRM1, GRM5, SMAD3 |
3.42111 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, GRM1, INSR, KIT, MIF, SRC |
3.42111 |
[BP] GO:0010676 |
None
|
ESRRB, GPER1, INSR, PPARA, SRC |
3.40365 |
[BP] GO:0043550 |
regulation of lipid kinase activity
|
F2, FLT3, KIT, SRC, TEK |
3.40365 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.40305 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, SMAD3, SRC, TEK, TERT |
3.39345 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, AR, BCL2, CYP1B1, ERBB2, FABP3, GPER1, HSPA1A, PTGES, SMAD3, TERT, XDH |
3.36059 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, BCL2, CYP19A1, ESR1, HSD17B2, INSR, KIT, SRC |
3.35922 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, APP, BCL2, EGFR, ERBB2, F2, GPER1, HCAR2, MIF, PRKCD, SMAD3, SRC |
3.3485 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DNMT1, EGFR, GPER1, GRM5, IGF1R, INSR, MMP2, PRKCD, SRC |
3.34475 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRB1, CACNA1C, EGFR, GPER1, GPR35, GRM1, HCAR2, KIT, SLC1A1, SMAD3 |
3.31943 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, APP, AR, BCL2, CSNK2A1, DNMT1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, F2, F3, FABP4, FLT3, GPER1, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP9, NUAK1, PRKCD, SMAD3, SRC, TEK, XDH |
3.3176 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
APP, DUSP3, EGFR, ERBB2, GPER1, KDR, MIF, SRC, TEK |
3.3176 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, AR, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, GPER1, SRC |
3.30246 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APP, GPER1, GRM5, IGF1R, INSR, PRKCD, SRC |
3.28808 |
[BP] GO:0035235 |
None
|
APP, GRIA2, GRIA4, GRIK5 |
3.28148 |
[BP] GO:0046686 |
response to cadmium ion
|
CYP1A2, EGFR, KIT, MMP9, TERT |
3.26979 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, F2, GPER1, MIF, PPARA, PRKCD, SMAD3, TEK |
3.26241 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, EGFR, HSPA1A, MAOA |
3.257 |
[BP] GO:1901184 |
None
|
ADORA1, APP, EGFR, ERBB2, GPER1, MMP9 |
3.23208 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
3.23208 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, CYP2D6, DUSP3, ESR1, FABP4, GPR35, GRM3, IGF1R, MET, MMP9, PIM1, PPARA, PRKCD, SRC |
3.23208 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DNMT1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PRKCD, PTGES, SMAD3, SRC, TBXAS1, TEK, TERT, TYR, XDH |
3.23208 |
[BP] GO:0055080 |
cation homeostasis
|
APP, BCL2, CA2, CA7, CACNA1C, EGFR, ESR1, F2, GPER1, GPR35, GRM1, GRM5, SMAD3 |
3.21818 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DYRK1A, EGFR, ESR1, KIT, PPARA, SRC |
3.2147 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, AXL, BCL2, CA3, CA9, CYP1A1, CYP1B1, EGFR, FABP3, KDR, POLB, PRKCD, SRC |
3.17001 |
[BP] GO:0006811 |
None
|
ABCB1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, FABP3, GRIA2, GRIA4, GRIK5, PPARA, SLC1A1 |
3.16563 |
[BP] GO:0007188 |
None
|
ADORA1, ADRB1, GPER1, GRM1, GRM3, GRM5, GRM8 |
3.15433 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, BCL2, CA2, EGFR, FLT3, GPER1, SRC |
3.14985 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.12236 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CYP1A1, DUSP3, EGFR, GPER1, INSR, MIF, SRC, TERT |
3.12236 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, BACE1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, FABP4, FUT7, HSPA1A, MAOA, MMP1, MMP2, MMP9, SRC, XDH |
3.11904 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD17B1, HSD17B2 |
3.11386 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, EGFR |
3.06053 |
[BP] GO:0035265 |
organ growth
|
AR, BCL2, CYP19A1, ESR1 |
3.06053 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC, TEK |
3.06053 |
[BP] GO:0040008 |
regulation of growth
|
ADRB1, APP, AR, BCL2, CSNK2A1, EGFR, ERBB2, ESR2, F2, HSPA1A, INSR, PIM1, SMAD3 |
3.06053 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
APP, BCL2, CA2, CA7, CACNA1C, ESR1, F2, GPER1, GPR35, GRIK5, GRM1, GRM5, SMAD3 |
3.06053 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.05067 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, PRKCD, SRC |
3.04523 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
APP, BCL2, CACNA1C, ESR1, F2, GPER1, GPR35, GRM1, GRM5, SMAD3 |
3.03873 |
[BP] GO:2001233 |
regulation of apoptotic signaling pathway
|
AR, BCL2, GPER1, HSPA1A, MIF, MMP9, PRKCD, SMAD3, SRC, TERT |
3.03873 |
[BP] GO:0030003 |
cellular cation homeostasis
|
APP, BCL2, CA2, CA7, CACNA1C, ESR1, F2, GPER1, GPR35, GRM1, GRM5, SMAD3 |
2.98836 |
[BP] GO:0048534 |
hematopoietic or lymphoid organ development
|
BCL2, FLT3, KDR, KIT, POLB, TEK, TYR |
2.98708 |
[BP] GO:0051222 |
positive regulation of protein transport
|
ACHE, APP, EGFR, ERBB2, F2, GPER1, HCAR2, MIF, PRKCD, SMAD3, SRC |
2.93019 |
[BP] GO:0055074 |
calcium ion homeostasis
|
APP, BCL2, CACNA1C, ESR1, F2, GPER1, GPR35, GRM1, GRM5, SMAD3 |
2.93002 |
[BP] GO:0002320 |
lymphoid progenitor cell differentiation
|
BCL2, FLT3, KIT |
2.93002 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
2.93002 |
[BP] GO:0001503 |
ossification
|
ALPL, BCL2, EGFR, MMP2, MMP9, TEK |
2.92699 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
2.91333 |
[BP] GO:0045913 |
None
|
ESRRB, GPER1, INSR, PPARA, SRC |
2.91109 |
[BP] GO:0006873 |
cellular ion homeostasis
|
APP, BCL2, CA2, CA7, CACNA1C, ESR1, F2, GPER1, GPR35, GRM1, GRM5, SMAD3 |
2.89777 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
APP, BCL2, CACNA1C, ESR1, F2, GPER1, GPR35, GRM1, GRM5, SMAD3 |
2.89531 |
[BP] GO:0019725 |
cellular homeostasis
|
APP, BCL2, CA2, CA7, CACNA1C, ESR1, F2, GPER1, GPR35, GRIK5, GRM1, GRM5, POLA1, SMAD3 |
2.89013 |
[BP] GO:0050793 |
regulation of developmental process
|
ADRB1, APP, AR, AXL, BCL2, CA2, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, ESRRB, F2, F3, GPER1, INSR, KDR, KIT, MIF, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TERT, XDH |
2.88829 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, EGFR, ESR1, F2, FABP4, GPER1, HSPA1A, MMP2, PPARA, PRKCD, SMAD3, SRC, TEK |
2.88682 |
[BP] GO:1903829 |
positive regulation of cellular protein localization
|
APP, BCL2, EGFR, ERBB2, F2, GPER1, PRKCD, SMAD3, SRC, TERT |
2.88267 |
[BP] GO:0048732 |
gland development
|
AR, BCL2, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
2.88267 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CYP1B1, F3, GPER1, KDR, KIT, TEK, TERT |
2.87973 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DNMT1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOA, MET, MIF, MMP1, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PRKCD, PTGES, SMAD3, SRC, TBXAS1, TEK, TERT, TYR, XDH |
2.86014 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRB1, APP, AR, AURKB, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DNMT1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, GRM8, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, NUAK1, PIM1, POLA1, PPARA, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
2.85099 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DNMT1, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGES, SRC |
2.83929 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.82436 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRB1, APP, AR, AURKB, BCL2, CA9, CSNK2A1, CYP1A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, GRM8, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, NUAK1, PIM1, POLA1, PPARA, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
2.81208 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, APP, AR, BCL2, CACNA1C, CSNK2A1, EGFR, ERBB2, F2, GPER1, HCAR2, MIF, PRKCD, SMAD3, SRC, TERT |
2.80893 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, EGFR, GPER1 |
2.80893 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APP, AR, AURKB, BCL2, CSNK2A1, CYP2D6, DNMT1, DUSP3, DYRK1A, ESR1, ESR2, ESRRA, F2, FABP4, GPER1, GRM3, GRM8, HSPA1A, IGF1R, MET, MIF, MMP9, PPARA, PRKCD, SMAD3, SRC, TERT, XDH |
2.80809 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, APP, AXL, BCL2, CA2, CYP19A1, DUSP3, ERBB2, ESR1, ESRRA, F2, GPER1, HCAR2, HSPA1A, KIT, MIF, MMP2, PRKCD, SMAD3, SRC |
2.79857 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, BCL2, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, KIT, SRC |
2.78902 |
[BP] GO:0007187 |
None
|
ADORA1, ADRB1, GPER1, GRM1, GRM3, GRM5, GRM8 |
2.77504 |
[BP] GO:0051128 |
regulation of cellular component organization
|
APP, AR, AURKB, AXL, BCL2, CSNK2A1, DNMT1, EGFR, ERBB2, ESR1, ESR2, F2, GPER1, GRIK5, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP9, PRKCD, SMAD3, SRC, TEK |
2.77102 |
[BP] GO:0071383 |
None
|
AR, EGFR, FLT3, GPER1, SRC |
2.76735 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, CACNA1C, EGFR, ERBB2, F2, GPER1, HCAR2, MIF, PRKCD, SMAD3, SRC |
2.76664 |
[BP] GO:1901342 |
regulation of vasculature development
|
CYP1B1, ERBB2, F3, GPER1, KDR, KIT, TEK, TERT, XDH |
2.76664 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
ADRB1, APP, AR, AURKB, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, GPER1, IGF1R, INSR, KDR, MET, PPARA, PRKCD, SMAD3, SRC, TERT |
2.76624 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRB1, APP, AR, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, CYP2D6, DNMT1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, GRM8, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, NUAK1, PIM1, POLA1, PPARA, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
2.7556 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, EGFR |
2.74579 |
[BP] GO:1903827 |
regulation of cellular protein localization
|
APP, AR, BCL2, CSNK2A1, EGFR, ERBB2, F2, GPER1, PRKCD, SMAD3, SRC, TERT |
2.74579 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.74317 |
[BP] GO:0007193 |
None
|
ADORA1, GRM1, GRM3, GRM5, GRM8 |
2.72749 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, TERT |
2.72749 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, GRM1, GRM5, INSR, KIT, MIF, PRKCD, SRC |
2.72749 |
[BP] GO:0060078 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5, GRM5 |
2.7031 |
[BP] GO:0046427 |
positive regulation of JAK-STAT cascade
|
AKR1B1, CYP1B1, F2, FLT3, KIT |
2.7031 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
AURKB, BCL2, DNMT1, GPER1, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
2.7031 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, GPER1, MMP2, MMP9, TERT |
2.70192 |
[BP] GO:1904705 |
regulation of vascular smooth muscle cell proliferation
|
GPER1, MMP2, MMP9, TERT |
2.68064 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, GPER1, SRC |
2.68064 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
AR, EGFR, ESR1, FLT3, GPER1, INSR, KIT, PRKCD, SRC |
2.66896 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.65883 |
[BP] GO:1904894 |
positive regulation of STAT cascade
|
AKR1B1, CYP1B1, F2, FLT3, KIT |
2.65881 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
ADRB1, APP, AR, AURKB, DNMT1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSPA1A, IGF1R, INSR, MET, PPARA, PRKCD, SMAD3, SRC, TERT |
2.6067 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
APP, EGFR, GPER1, KDR, MIF, SRC, TEK |
2.60508 |
[BP] GO:0001775 |
cell activation
|
ALOX5, APP, AXL, BCL2, EGFR, F2, FLT3, FUT7, HSPA1A, KIT, MIF, MMP9, PRKCD, SMAD3, SRC |
2.60508 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, GRM1, INSR, KIT, MIF, SRC |
2.60014 |
[BP] GO:0034762 |
None
|
ABCB1, APP, BCL2, CA2, CACNA1C, F2, GPER1, GPR35, GRM5, MMP9 |
2.60014 |
[BP] GO:0048729 |
tissue morphogenesis
|
AR, BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.5637 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, F2, F3, FLT3, FUT7, HSPA1A, IGF1R, INSR, KDR, KIT, MAOA, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, POLB, PPARA, PRKCD, SMAD3, SRC, TEK, TYR, XDH |
2.5628 |
[BP] GO:0065007 |
biological regulation
|
ABCB1, ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DNMT1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, GPER1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOA, MET, MIF, MMP1, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PRKCD, PTGES, SLC1A1, SMAD3, SRC, TEK, TERT, XDH |
2.54911 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PIM1, PPARA, PTGES, TBXAS1, TYR |
2.53948 |
[BP] GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC, TEK |
2.53039 |
[BP] GO:0055065 |
metal ion homeostasis
|
APP, BCL2, CACNA1C, EGFR, ESR1, F2, GPER1, GPR35, GRM1, GRM5, SMAD3 |
2.5249 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
EGFR, F2, F3, FABP4, KDR, MET, MIF, SMAD3 |
2.51468 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DUSP3, DYRK1A, EGFR, HSPA1A, IGF1R, MET, MIF, NUAK1, PRKCD, TERT, XDH |
2.50521 |
[BP] GO:0042058 |
None
|
ADORA1, APP, EGFR, GPER1, MMP9 |
2.50148 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, GPER1, MMP9, SMAD3, SRC, XDH |
2.50104 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.50104 |
[BP] GO:0070920 |
None
|
EGFR, ESR1, TERT |
2.50104 |
[BP] GO:0007154 |
None
|
ADORA1, ADRB1, AR, AXL, BCL2, CACNA1C, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, TEK |
2.49945 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
APP, AR, AXL, BCL2, CA2, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, F2, F3, GPER1, INSR, KDR, KIT, PIM1, SMAD3, SRC, TEK, TERT, XDH |
2.48745 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRB1, APP, AR, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, DNMT1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, GRM8, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, NUAK1, PIM1, POLA1, PPARA, PRKCD, SMAD3, SRC, TEK, TERT, XDH |
2.46703 |
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
CACNA1C, ESR1, F2, GPER1, GPR35, GRM1, GRM5, SMAD3 |
2.46142 |
[BP] GO:0051172 |
None
|
APP, AR, AURKB, CSNK2A1, DNMT1, DUSP3, DYRK1A, EGFR, ESR1, ESR2, ESRRA, F2, FABP4, GPER1, GRM3, GRM8, HSPA1A, IGF1R, MIF, MMP9, PPARA, PRKCD, SMAD3, SRC, TERT, XDH |
2.44764 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, BCL2, HSPA1A, MIF, MMP9, SRC, TERT |
2.44557 |
[BP] GO:0060341 |
regulation of cellular localization
|
APP, AR, BCL2, CACNA1C, CSNK2A1, EGFR, ERBB2, F2, GPER1, GRIK5, PRKCD, SMAD3, SRC, TERT |
2.43362 |
[BP] GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress
|
BCL2, CYP1B1, PRKCD |
2.43362 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.43362 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.43362 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.43362 |
[BP] GO:0002520 |
None
|
CACNA1C, SMAD3 |
2.43362 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, DNMT1, EGFR, IGF1R, INSR, PRKCD, SRC |
2.43105 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AR, AXL, BCL2, CA2, CYP1B1, ESRRB, F3, GPER1, INSR, KDR, KIT, PIM1, SMAD3, SRC, TEK, TERT |
2.37054 |
[BP] GO:2000351 |
None
|
GPER1, KDR, TEK, TERT |
2.33712 |
[BP] GO:1900180 |
regulation of protein localization to nucleus
|
APP, EGFR, F2, PRKCD, SMAD3, SRC, TERT |
2.33501 |
[BP] GO:0051093 |
None
|
ADRB1, APP, BCL2, EGFR, ERBB2, ESRRB, F2, GPER1, MIF, PPARA, SMAD3, TEK, TERT, XDH |
2.3286 |
[BP] GO:1905475 |
None
|
AR, BCL2, CSNK2A1, EGFR, ERBB2, GPER1 |
2.32668 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MIF, MMP9, SRC |
2.32544 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, AR, CYP1B1, ESR1, ESR2, HSPA1A, KIT, PIM1 |
2.31329 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, FLT3, GPER1, SRC |
2.30208 |
[BP] GO:0003018 |
None
|
ADORA1, ADRB1, EGFR, GPER1, SRC, TEK |
2.30208 |
[BP] GO:2001236 |
regulation of extrinsic apoptotic signaling pathway
|
AR, BCL2, GPER1, HSPA1A, SRC, TERT |
2.30208 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.30194 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
APP, BCL2, CACNA1C, ESR1, F2, GPER1, GPR35, GRM1, GRM5, SMAD3 |
2.29442 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, EGFR, F2, GPER1, HCAR2 |
2.28841 |
[BP] GO:0042307 |
positive regulation of protein import into nucleus
|
APP, EGFR, F2, PRKCD, SMAD3 |
2.27423 |
[BP] GO:0050994 |
None
|
ADORA1, HCAR2, PPARA, PRKCD |
2.25374 |
[BP] GO:0023052 |
None
|
ADORA1, ADRB1, AR, CACNA1C, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, TEK |
2.25177 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.23898 |
[BP] GO:1904591 |
positive regulation of protein import
|
APP, EGFR, F2, PRKCD, SMAD3 |
2.23898 |
[BP] GO:0000904 |
cell morphogenesis involved in differentiation
|
AR, AXL, MET, SRC, TEK |
2.23898 |
[BP] GO:0007568 |
aging
|
AURKB, BCL2, CYP1A1, MIF, POLB, PRKCD, TERT |
2.23874 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.22374 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.22374 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.22374 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.22374 |
[BP] GO:1900542 |
None
|
ADRB1, ESRRB, GPER1, GRM3, GRM8, INSR, PPARA |
2.20913 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.20558 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.20394 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.20394 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, GPER1, MMP9, SMAD3, SRC, XDH |
2.1917 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, KDR, SMAD3, SRC, TEK |
2.1917 |
[BP] GO:2001237 |
negative regulation of extrinsic apoptotic signaling pathway
|
AR, BCL2, HSPA1A, SRC, TERT |
2.1917 |
[BP] GO:0070201 |
None
|
ACHE, APP, BCL2, CACNA1C, EGFR, ERBB2, F2, GPER1, HCAR2, MIF, PRKCD, SMAD3, SRC |
2.18881 |
[BP] GO:0051336 |
regulation of hydrolase activity
|
ADRB1, APP, CSNK2A1, EGFR, ERBB2, ESR1, F3, GPER1, HSPA1A, KIT, MMP9, NUAK1, PRKCD, SMAD3, SRC, XDH |
2.18458 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.18458 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.18458 |
[BP] GO:0009653 |
anatomical structure morphogenesis
|
APP, AR, AXL, BCL2, CA2, CA9, CACNA1C, CYP1B1, EGFR, ESR1, INSR, MET, MMP2, POLB, SMAD3, SRC, TEK |
2.18078 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CYP1B1, F3, GPER1, GRIK5, HCAR2, MMP9, PRKCD, SMAD3, SRC, XDH |
2.18078 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PIM1, PPARA, PTGES, TBXAS1, TYR |
2.16356 |
[BP] GO:0006140 |
None
|
ADRB1, ESRRB, GPER1, GRM3, GRM8, INSR, PPARA |
2.15006 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CYP1B1, F3, GPER1, GRIK5, HCAR2, MMP9, PRKCD, SMAD3, SRC, XDH |
2.14804 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, MAOA, TYR |
2.14804 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, EGFR, F2, FUT7, KDR, KIT, MIF, MMP1, MMP9, PRKCD, SRC, TEK |
2.14804 |
[BP] GO:0022612 |
gland morphogenesis
|
BCL2, EGFR, POLB |
2.14804 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.14804 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.14804 |
[BP] GO:0032409 |
None
|
ABCB1, APP, BCL2, GPR35, GRM5, MMP9, PRKCD |
2.1458 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.13692 |
[BP] GO:0050866 |
negative regulation of cell activation
|
AXL, DUSP3, ERBB2, F2, GPER1, PRKCD |
2.13104 |
[BP] GO:0008406 |
gonad development
|
BCL2, CYP19A1, ESR1, INSR, KIT |
2.11943 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, EGFR, ERBB2, INSR, KDR, SMAD3, SRC |
2.11891 |
[BP] GO:0050678 |
None
|
AR, EGFR, ERBB2, F3, KDR, SMAD3, TEK, XDH |
2.10323 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PIM1, PPARA, PTGES, TBXAS1, TYR |
2.10076 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.10033 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, FLT3, GRM5, KIT, MIF, SRC |
2.09921 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ADRB1, ALPL, APP, AR, AXL, BCL2, CYP1A1, EGFR, ERBB2, ESR1, ESRRB, FABP4, FLT3, FUT7, KDR, KIT, MET, MIF, MMP2, MMP9, PRKCD, SMAD3, SRC, TEK, TERT |
2.09041 |
[BP] GO:0007267 |
None
|
ADORA1, ADRB1, AR, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, TEK |
2.08743 |
[BP] GO:0051345 |
None
|
ADRB1, APP, EGFR, ERBB2, ESR1, F3, GPER1, HSPA1A, KIT, PRKCD, SMAD3, XDH |
2.07794 |
[BP] GO:0050679 |
None
|
AR, EGFR, ERBB2, F3, KDR, TEK |
2.07678 |
[BP] GO:0035295 |
tube development
|
AKR1B1, AR, CYP1A1, EGFR, KIT, SMAD3 |
2.07678 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CYP19A1, CYP1A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, KIT, MMP2, MMP9, SRC |
2.06842 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.05318 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.05318 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, PRKCD |
2.04311 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, EGFR, SRC |
2.04311 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
ADRB1, APP, AR, AURKB, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, IGF1R, INSR, MET, PPARA, PRKCD, SMAD3, SRC, TERT |
2.04311 |
[BP] GO:0045927 |
positive regulation of growth
|
BCL2, CSNK2A1, EGFR, ERBB2, F2, INSR, PIM1 |
2.03189 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, EGFR, GPER1, HCAR2, MIF, SRC |
2.03189 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2A6, CYP2D6, MAOA |
2.03189 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
2.03189 |
[BP] GO:0006954 |
inflammatory response
|
ADORA1, ADORA3, AXL, F2, GPER1, KIT, MIF, POLB, PTGES |
2.01925 |
[BP] GO:0044419 |
interspecies interaction between organisms
|
AXL, DYRK1A, EGFR, F2, HSPA1A, INSR, KDR, MET, MMP1, POLA1, SMAD3, SRC |
2.01312 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.01101 |
[BP] GO:0048169 |
None
|
APP, GRM5, KIT |
2.01101 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.01032 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.01032 |
[BP] GO:0007423 |
None
|
BCL2, CACNA1C, CYP1A1, EGFR, KIT |
2.00477 |
[BP] GO:0050920 |
regulation of chemotaxis
|
CYP19A1, F3, KDR, MET, MIF, SMAD3 |
2.00461 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ADRB1, ALPL, APP, AR, AXL, BACE1, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, EGFR, ERBB2, ESR1, F2, F3, FLT3, GPER1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, KIT, MET, MMP2, PIM1, PRKCD, SLC1A1, SMAD3, SRC, TEK, TERT |
5.78638 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ADORA1, ADORA3, ADRB1, APP, AXL, BACE1, CA2, CA4, CA9, CACNA1C, DUSP3, EGFR, ERBB2, F2, F3, FLT3, GPER1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, KIT, MET, SLC1A1, SRC, TEK |
5.51198 |
[CC] GO:0098590 |
plasma membrane region
|
ABCB1, ADORA1, CA2, CA4, CA9, EGFR, ERBB2, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, INSR, MET, SLC1A1, SRC, TEK |
5.4137 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ADRB1, ALOX5, ALPL, APP, AR, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, EGFR, ERBB2, ESR1, F2, F3, FLT3, FUT7, GPER1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD17B2, IGF1R, INSR, KDR, KIT, MAOA, MET, MMP2, PIM1, PRKCD, PTGES, SLC1A1, SMAD3, SRC, TBXAS1, TEK, TERT, TYR |
4.94108 |
[CC] GO:0042734 |
None
|
GPER1, GRIK5, GRM1, GRM3, GRM5, GRM8 |
4.26735 |
[CC] GO:0044425 |
membrane part
|
ABCB1, ACHE, ADORA1, ADORA3, ADRB1, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DUSP3, EGFR, ERBB2, ESR1, F2, F3, FLT3, FUT7, GPER1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD17B2, IGF1R, INSR, KDR, KIT, MAOA, MET, PTGES, SLC1A1, SRC, TBXAS1, TEK, TYR |
4.15754 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRB1, APP, AXL, BACE1, CA4, F3, FLT3, GPER1, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, SLC1A1, TEK |
4.01521 |
[CC] GO:0043235 |
receptor complex
|
APP, EGFR, ERBB2, GRIA2, GRIA4, GRIK5, GRM1, IGF1R, INSR, SMAD3 |
3.57743 |
[CC] GO:0014069 |
None
|
ADORA1, CACNA1C, GPER1, GRIK5, GRM1, GRM3, GRM5, SRC |
3.41853 |
[CC] GO:0099572 |
None
|
ADORA1, CACNA1C, GPER1, GRIK5, GRM1, GRM3, GRM5, SRC |
3.41853 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ABCB1, ACHE, ADORA1, ADRB1, AKR1B1, AKR1B10, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DNMT1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, FUT7, GPER1, GRIA4, GRIK5, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, KIT, MAOA, MIF, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PRKCD, SHBG, SLC1A1, SMAD3, SRC, TERT, TYR, XDH |
3.39759 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.32959 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRB1, APP, AXL, BACE1, FLT3, GPER1, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, SLC1A1, TEK |
3.24955 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BACE1, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, EGFR, F2, FLT3, GPER1, GRIA2, HSD11B1, HSD17B2, PTGES, TBXAS1 |
3.21818 |
[CC] GO:0043226 |
organelle
|
ABCB1, ACHE, ADORA1, ADRB1, AKR1B1, AKR1B10, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA6, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DNMT1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, FUT7, GPER1, GRIA4, GRIK5, GRM1, GRM3, GRM5, HSPA1A, IGF1R, INSR, KDR, KIT, MAOA, MIF, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PRKCD, SHBG, SLC1A1, SMAD3, SRC, TERT, TYR, XDH |
2.89531 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, APP, CACNA1C, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SRC |
2.81992 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, EGFR, GPER1, GRIA2, HSD11B1, HSD17B2, PTGES, TBXAS1 |
2.7863 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, ERBB2, TEK |
2.74278 |
[CC] GO:0009986 |
cell surface
|
ABCB1, ACHE, APP, AXL, BACE1, CA4, EGFR, F3, MET, MIF, TEK |
2.54174 |
[CC] GO:0048471 |
perinuclear region of cytoplasm
|
ACHE, AKR1B1, APP, CA4, EGFR, ERBB2, GPER1, HSPA1A, PRKCD, PTGES, SRC, TYR |
2.52217 |
[CC] GO:0097060 |
None
|
GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
2.44357 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRB1, AKR1B1, AKR1B10, ALOX5, AOX1, APP, AR, AURKB, BACE1, BCL2, CA1, CA2, CA3, CA4, CA5A, CA5B, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DUSP3, EGFR, ERBB2, ESR1, ESR2, F2, FABP3, FABP4, FLT3, FUT7, GPER1, GRIA2, GRIA4, GRIK5, HSD11B1, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, KIT, MAOA, MIF, MMP2, MMP9, PIM1, POLA1, PRKCD, PTGES, SMAD3, SRC, TBXAS1, TERT, TYR, XDH |
2.32054 |
[CC] GO:0031982 |
None
|
ABCB1, ADRB1, AKR1B1, AKR1B10, ALPL, AOX1, APP, AXL, BACE1, CA1, CA2, CA4, CA6, DUSP3, EGFR, F2, F3, FABP3, FABP4, GPER1, GRIA4, GRM5, HSPA1A, INSR, KDR, KIT, MIF, MMP9, PRKCD, SHBG, SLC1A1, SRC, TYR |
2.11891 |
[CC] GO:0031224 |
None
|
ABCB1, ACHE, ADORA1, ADORA3, ADRB1, ALPL, APP, AXL, BACE1, CA12, CA14, CA4, CA9, CACNA1C, EGFR, ERBB2, ESR1, F3, FLT3, FUT7, GPER1, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD17B2, IGF1R, INSR, KDR, KIT, MAOA, MET, PTGES, SLC1A1, TBXAS1, TEK, TYR |
2.03189 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
18.4011 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, AR, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DNMT1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PIM1, PPARA, SMAD3, TBXAS1, TYR, XDH |
16.1983 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PRKCD, PTGES, SLC1A1, SMAD3, SRC, TBXAS1, TEK, TERT, TYR, XDH |
11.9185 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, POLB |
11.5651 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.5651 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BACE1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DNMT1, DUSP3, DYRK1A, EGFR, ERBB2, F2, F3, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOA, MET, MIF, MMP1, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PRKCD, PTGES, SRC, TBXAS1, TEK, TERT, TYR, XDH |
11.5651 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRB1, AR, AXL, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GPER1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, KIT, MET, PPARA, TEK |
10.1838 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, TEK |
9.54971 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRB1, AR, AXL, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GPER1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, KIT, MET, PPARA, TEK |
8.85937 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, DYRK1A, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, PRKCD, SRC, TEK |
8.62623 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRB1, AR, AXL, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GPER1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, KIT, MET, PPARA, SMAD3, TEK |
8.58841 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRB1, AR, AXL, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GPER1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, KIT, MET, PPARA, TEK |
8.58841 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, TEK |
8.58841 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
7.85683 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.78054 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, POLB |
7.54739 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DNMT1, ESR1, ESR2, ESRRA, ESRRB, F2, KIT, MMP1, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PRKCD, SLC1A1, SMAD3, TBXAS1, TERT, TYR, XDH |
7.37127 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DNMT1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PPARA, SMAD3 |
7.26427 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DNMT1, ESR1, ESR2, ESRRA, ESRRB, F2, KIT, MMP1, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PRKCD, SLC1A1, SMAD3, TBXAS1, TERT, TYR, XDH |
7.21439 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TBXAS1, XDH |
7.09771 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, ERBB2, INSR, KDR, KIT |
7.07036 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TBXAS1, TYR |
6.72282 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
6.63366 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, EGFR, ERBB2, F3, FLT3, GPER1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, KIT, MET, TEK |
6.25957 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, EGFR, ERBB2, F3, FLT3, GPER1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, KIT, MET, TEK |
6.25957 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA |
6.15643 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA |
6.15643 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, EGFR, GPER1, HSD17B1, IGF1R, INSR, SHBG |
5.87236 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSD17B1, SHBG |
5.83582 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD11B1, HSD17B1, HSD17B2, MAOA, TBXAS1, TYR, XDH |
5.8294 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PRKCD, SRC, TEK |
5.74369 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, SRC, TBXAS1 |
5.74369 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA |
5.65862 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, DYRK1A, EGFR, ERBB2, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PPARA, PRKCD, SRC, TEK |
5.58056 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, SRC, TBXAS1 |
5.51211 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, DYRK1A, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, POLA1, POLB, PRKCD, SRC, TEK, TERT |
5.20855 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TBXAS1, TYR |
5.127 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD17B1, POLA1, PTGES, SRC, TBXAS1, XDH |
5.06911 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
5.0226 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, DYRK1A, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PRKCD, SRC, TEK |
4.7591 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PRKCD, SRC, TEK |
4.26735 |
[MF] GO:0019899 |
enzyme binding
|
ADRB1, APP, AR, AURKB, BACE1, BCL2, CYP1A1, CYP1A2, CYP2A6, DUSP3, EGFR, ERBB2, ESR1, ESR2, ESRRB, F3, GRM5, HSPA1A, KIT, MET, MIF, POLA1, POLB, PPARA, PRKCD, SMAD3, SRC, TEK |
4.25791 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
4.22582 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2, GPER1 |
3.976 |
[MF] GO:0005057 |
signal transducer activity, downstream of receptor
|
ADRB1, EGFR, ERBB2, INSR, KDR, KIT, SMAD3 |
3.76033 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, GPER1, HSD17B1, PPARA, SHBG |
3.52057 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD17B1, HSD17B2, XDH |
3.47455 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, ADORA1, AOX1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, EGFR, ERBB2, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, POLA1, PRKCD, SLC1A1, SRC, TEK, XDH |
3.43121 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, APP, BCL2, CSNK2A1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, FLT3, GRIK5, IGF1R, KDR, KIT, MET, MIF, MMP9, SMAD3, TERT, TYR, XDH |
3.3754 |
[MF] GO:0043168 |
anion binding
|
ABCB1, AOX1, APP, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, ERBB2, F2, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PRKCD, PTGES, SLC1A1, SRC, TEK, XDH |
3.01481 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, INSR, PRKCD |
2.93002 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.82436 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.82436 |
[MF] GO:0000166 |
nucleotide binding
|
ABCB1, AOX1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, EGFR, ERBB2, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, POLA1, PRKCD, SRC, TEK, XDH |
2.74229 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCB1, AOX1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, EGFR, ERBB2, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, POLA1, PRKCD, SRC, TEK, XDH |
2.74017 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, ERBB2, IGF1R, INSR, KDR, TEK |
2.66896 |
[MF] GO:0005524 |
ATP binding
|
ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, ERBB2, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PRKCD, SRC, TEK |
2.53859 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.50104 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.43362 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, ERBB2, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PRKCD, SRC, TEK |
2.43105 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, ERBB2, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PRKCD, SRC, TEK |
2.3939 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.30194 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.30194 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ABCB1, ADORA1, ADRB1, AOX1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DNMT1, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, POLA1, POLB, PPARA, PRKCD, SHBG, SMAD3, SRC, TBXAS1, TEK, TERT, XDH |
2.27942 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.24028 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, ERBB2, MET, PPARA, SMAD3 |
2.1917 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.18458 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.18458 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.18458 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.18458 |
[MF] GO:0003674 |
molecular_function
|
ABCB1, ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DNMT1, DUSP3, DYRK1A, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, FUT7, GPER1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOA, MET, MIF, MMP1, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PRKCD, PTGES, SHBG, SLC1A1, SMAD3, SRC, TBXAS1, TEK, TERT, TYR, XDH |
2.17135 |
[MF] GO:0097367 |
carbohydrate derivative binding
|
ABCB1, ADORA1, APP, AURKB, AXL, CSNK2A1, DYRK1A, EGFR, ERBB2, F2, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, POLA1, PRKCD, SRC, TEK |
2.12405 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.11943 |
[MF] GO:0030594 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
2.10351 |
[MF] GO:0001540 |
amyloid-beta binding
|
ACHE, BACE1, GRIA2, INSR |
2.06718 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP9, PIM1, PPARA, SMAD3, SRC |
2.01925 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.01032 |